IRIS MELANOMA

Clinical trials for IRIS MELANOMA explained in plain language.

Never miss a new study

Get alerted when new IRIS MELANOMA trials appear

Sign up with your email to follow new studies for IRIS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Immune cell therapy shows promise for Hard-to-Treat melanoma

Disease control Completed

This early-phase study tested a new treatment called TBio-4101 for people with advanced melanoma that did not respond to standard therapies. The treatment uses a patient's own immune cells (TILs) that are grown in a lab and given back after chemotherapy and a drug called IL-2. Th…

Matched conditions: IRIS MELANOMA

Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated May 15, 2026 11:53 UTC

IRIS MELANOMA

Get alerted when new IRIS MELANOMA trials appear

Immune cell therapy shows promise for Hard-to-Treat melanoma